Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

Brent L. Wood, Meenakshi Devidas, Ryan J. Summers, Zhiguo Chen, Barbara Asselin, Karen R. Rabin, Patrick A. Zweidler-McKay, Naomi J. Winick, Michael J. Borowitz, William L. Carroll, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger, Kimberly P. Dunsmore, David T. Teachey, Stuart S. Winter

Blood (2023) 142 (24): 2069–2078.

https://doi.org/10.1182/blood.2023020678

Published: 2023

Includes: Supplemental data

Journal Articles

Risk-Adjusted Therapies Yield Equivalent Outcomes for Adolescents and Young Adults (AYAs) Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) on Children's Oncology Group (COG) Studies AALL0434 and AALL1231

Susan I. Colace, Meenakshi Devidas, Zhiguo (Bruce) Chen, Robert J. Hayashi, Brent L. Wood, Natia Esiashvili, Samir Patel, Andrew J Carroll, Nyla A. Heerema, Barbara Asselin, Karen R. Rabin, Patrick A. Zweidler-McKay, Elizabeth A. Raetz, Mignon L. Loh, Naomi J. Winick, William L. Carroll, David T. Teachey, Stuart S. Winter, Kimberly P. Dunsmore

Blood (2023) 142 (Supplement 1): 517.

https://doi.org/10.1182/blood-2023-190141

Published: 2023

Journal Articles

Mixed Lineage Leukemia Rearrangements ( MLL- R ) Are Determinants of High Risk Disease in Homeobox A (HOXA)- deregulated T-Lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Blood (2015) 126 (23): 694.

https://doi.org/10.1182/blood.V126.23.694.694

Published: 2015

Journal Articles

Capizzi-Style Methotrexate with Pegasparagase (C-MTX) Is Superior to High-Dose Methotrexate (HDMTX) in T-Lineage Acute Lymphoblastic Leukemia (T-ALL): Results from Children's Oncology Group (COG) AALL0434

Stuart S. Winter, MD, Meenakshi Devidas, PhD, Si Chen, MS, Barbara Asselin, MD, William L. Carroll, MD, Brent L Wood, MD PhD, Natia Esiashvili, MD, Briegel J Nikki, PharmD, Robert J. Hayashi, MD, Mignon L. Loh, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Elizabeth Raetz, MD, Naomi J. Winick, MD, Stephen P. Hunger, MD, Kimberly P. Dunsmore, MD

Blood (2015) 126 (23): 794.

https://doi.org/10.1182/blood.V126.23.794.794

Published: 2015

Journal Articles

Effect of High-Dose Methotrexate (HD-MTX) Vs Capizzi Methotrexate/Pegaspargase (C-MTX/ASNase) on Osteonecrosis (ON) Incidence in Children and Young Adults with T-Acute Lymphoblastic Leukemia (T-ALL): Results of Children’s Oncology Group (COG) Study AALL0434

Leonard A. Mattano, MD, Meenakshi Devidas, PhD, Si Chen, MS, Natia Esiashvili, MD, Barbara Asselin, MD, Naomi J. Winick, MD, Mignon Loh, MD, Elizabeth A Raetz, MD, Stephen Hunger, MD, William L. Carroll, MD, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD

Blood (2014) 124 (21): 3649.

https://doi.org/10.1182/blood.V124.21.3649.3649

Published: 2014

Journal Articles

T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434

Brent L. Wood, MD PhD, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD, Meenakshi Devidas, PhD, Si Chen, Barbara Asselin, MD, Natia Esiashvili, MD, Mignon L. Loh, MD, Naomi J. Winick, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Stephen P. Hunger, MD

Blood (2014) 124 (21): 1.

https://doi.org/10.1182/blood.V124.21.1.1

Published: 2014

Journal Articles

Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL

Lewis B. Silverman, MD, Kristen E. Stevenson, MS, Uma H. Athale, M.D., M.Sc., Luis A. Clavell, MD, Peter Cole, MD, Kara A. Kelly, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD, FRCPC, Marshall A. Schorin, MD, Cindy L Schwartz, MD, MPH, Barbara Asselin, MD, Jeffrey G Supko, PhD, Sarah Hunt, MPH, Place Andrew, MD, PhD, Lynda M. Vrooman, MD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD

Blood (2013) 122 (21): 838.

https://doi.org/10.1182/blood.V122.21.838.838

Published: 2013

Journal Articles

Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group

Wanda L. Salzer, Barbara Asselin, Jeffrey G. Supko, Meenakshi Devidas, Nicole A. Kaiser, Paul Plourde, Naomi J. Winick, Gregory H. Reaman, Elizabeth Raetz, William L. Carroll, Stephen P. Hunger

Blood (2013) 122 (4): 507–514.

https://doi.org/10.1182/blood-2013-01-480822

Published: 2013

Journal Articles

Expression Profiling for MEIS1 and HOXA9/10 Identifies an Increased Incidence of MLL Rearrangements in T-ALL: A Children's Oncology Group Study.

Ksenia Matlawska-Wasowska, PhD, Richard C. Harvey, PhD, I-Ming Chen, DVM, Cheryl L Willman, MD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Meenakshi Devidas, PhD, Mignon L. Loh, MD, Stephen P. Hunger, MD, Elizabeth Raetz, MD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Barbara Asselin, MD, Naomi Winick, MD, William L. Carroll, MD, Richard S. Larson, MD, PhD, Kimberly P. Dunsmore, MD, Stuart S. Winter, MD

Blood (2012) 120 (21): 2505.

https://doi.org/10.1182/blood.V120.21.2505.2505

Published: 2012

Journal Articles

Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01

Lewis B. Silverman, MD, Kristen Stevenson, Lynda M Vrooman, MD, Jeffrey G Supko, PhD, Barbara Asselin, MD, Uma Athale, MD, Luis A. Clavell, MD, Peter Cole, MD, Kara M Kelly, MD, Caroline Laverdiere, MD, Bruno Michon, MD, FRCPC, Marshall A. Schorin, MD, Cindy Schwartz, MD, MPH, Donna Neuberg, ScD, Stephen E. Sallan, MD

Blood (2011) 118 (21): 874.

https://doi.org/10.1182/blood.V118.21.874.874

Published: 2011

Journal Articles

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Stuart S. Winter, MD, Meenakshi Devidas, PhD, Brent Wood, MD, PhD, Michael J. Borowitz, MD, PhD, Mignon L. Loh, M.D., Barbara Asselin, MD, John Murphy, Elizabeth Raetz, MD, Naomi Winick, MD, Stephen Hunger, MD, William Carroll, MD, Kimberly Dunsmore, MD

Blood (2010) 116 (21): 865.

https://doi.org/10.1182/blood.V116.21.865.865

Published: 2010

Journal Articles

Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Pediatric Patients with Malignant Disorders

Shalini Shenoy, MD, Barbara Asselin, Jignesh Dalal, Rakesh Goyal, Jonathan L. Kaufman, MD, David Loeb, John McCarty, Kent Robertson, Caron Strahlendorf, Mark C. Walters, MD, Jennifer Angell, Dirk Huebner, MD, Peter J. Shaw, MA, MB, BS, MRCP, FRACP

Blood (2010) 116 (21): 2245.

https://doi.org/10.1182/blood.V116.21.2245.2245

Published: 2010

Journal Articles

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Wanda Salzer, MD, Barbara Asselin, MD, Jeffrey Supko, PhD, Meenakshi Devidas, PhD, Nicole Kaiser, RPh, Paul V. Plourde, MD, Naomi Winick, MD, Gregory Reaman, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen Hunger, MD

Blood (2010) 116 (21): 2134.

https://doi.org/10.1182/blood.V116.21.2134.2134

Published: 2010

Journal Articles

Identification of Genomic Classifiers That Distinguish Induction Failure in T-Lineage Acute Lymphoblastic Leukemia in COG Study 9404.

Stuart S. Winter, MD, Hadya Khawaja, Zeyu Jiang, PhD, Timothy Griffin, MD, Barbara Asselin, MD, Richard S. Larson, MD, PhD

Blood (2006) 108 (11): 1826.

https://doi.org/10.1182/blood.V108.11.1826.1826

Published: 2006

Journal Articles

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Albert Moghrabi, Donna E. Levy, Barbara Asselin, Ronald Barr, Luis Clavell, Craig Hurwitz, Yvan Samson, Marshall Schorin, Virginia K. Dalton, Steven E. Lipshultz, Donna S. Neuberg, Richard D. Gelber, Harvey J. Cohen, Stephen E. Sallan, Lewis B. Silverman

Blood (2006) 109 (3): 896–904.

https://doi.org/10.1182/blood-2006-06-027714

Published: 2006

NARROW

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

Risk-Adjusted Therapies Yield Equivalent Outcomes for Adolescents and Young Adults (AYAs) Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) on Children's Oncology Group (COG) Studies AALL0434 and AALL1231

Mixed Lineage Leukemia Rearrangements ( MLL- R ) Are Determinants of High Risk Disease in Homeobox A (HOXA)- deregulated T-Lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Capizzi-Style Methotrexate with Pegasparagase (C-MTX) Is Superior to High-Dose Methotrexate (HDMTX) in T-Lineage Acute Lymphoblastic Leukemia (T-ALL): Results from Children's Oncology Group (COG) AALL0434

Effect of High-Dose Methotrexate (HD-MTX) Vs Capizzi Methotrexate/Pegaspargase (C-MTX/ASNase) on Osteonecrosis (ON) Incidence in Children and Young Adults with T-Acute Lymphoblastic Leukemia (T-ALL): Results of Children’s Oncology Group (COG) Study AALL0434

T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434

Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL

Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group

Expression Profiling for MEIS1 and HOXA9/10 Identifies an Increased Incidence of MLL Rearrangements in T-ALL: A Children's Oncology Group Study.

Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Pediatric Patients with Malignant Disorders

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Identification of Genomic Classifiers That Distinguish Induction Failure in T-Lineage Acute Lymphoblastic Leukemia in COG Study 9404.

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only